Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LMO7 mRNA] | CTD | PMID:31150632 | (S)-nicotine | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Nicotine results in decreased expression of LMO7 mRNA | CTD | PMID:21955143 | 1,2-dichloroethane | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of LMO7 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LMO7 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of LMO7 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of LMO7 mRNA and EGF protein inhibits the reaction [Estradiol results in decreased expression of LMO7 mRNA] | CTD | PMID:24758408 and PMID:30165855 | 17beta-estradiol | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of LMO7 mRNA | CTD | PMID:24758408 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA] | CTD | PMID:11007951 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lmo7 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LMO7 mRNA | CTD | PMID:18343893 and PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA | CTD | PMID:23238561 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA | CTD | PMID:18796159 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA | CTD | PMID:11007951 more ... | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | LMO7 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LMO7 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of LMO7 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LMO7 gene] | CTD | PMID:16214954 and PMID:21762485 | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | ISO | Lmo7 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:18343893 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of LMO7 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of LMO7 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of LMO7 mRNA | CTD | PMID:30851411 | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 4,4'-diaminodiphenylmethane | affects expression | ISO | Lmo7 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane affects the expression of LMO7 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | bisphenol S results in increased expression of LMO7 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Lmo7 (Mus musculus) | 6480464 | bisphenol S affects the methylation of LMO7 gene | CTD | PMID:31683443 | 4,4'-sulfonyldiphenol | affects expression | ISO | LMO7 (Homo sapiens) | 6480464 | bisphenol S affects the expression of LMO7 protein | CTD | PMID:31945527 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of LMO7 gene | CTD | PMID:31601247 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of LMO7 mRNA | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Fenretinide results in increased expression of LMO7 mRNA | CTD | PMID:28973697 | acetylsalicylic acid | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Aspirin results in increased expression of LMO7 mRNA | CTD | PMID:15456535 | acrolein | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LMO7 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LMO7 mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of LMO7 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases methylation | ISO | LMO7 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of LMO7 gene | CTD | PMID:27153756 | Aflatoxin B2 alpha | decreases methylation | ISO | LMO7 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of LMO7 promoter | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of LMO7 mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of LMO7 mRNA | CTD | PMID:30951980 | alpha-pinene | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LMO7 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LMO7 mRNA | CTD | PMID:32699268 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of LMO7 mRNA | CTD | PMID:30779732 | aristolochic acid A | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of LMO7 mRNA | CTD | PMID:33212167 | arsane | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA | CTD | PMID:32525701 | arsenite(3-) | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to LMO7 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of LMO7 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | affects methylation | ISO | LMO7 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LMO7 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | LMO7 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of LMO7 exon | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 | Benzo[k]fluoranthene | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in increased expression of LMO7 mRNA | CTD | PMID:26377693 | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LMO7 mRNA | CTD | PMID:18164116 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LMO7 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | ISO | LMO7 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of LMO7 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of LMO7 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LMO7 mRNA | CTD | PMID:32145629 | bisphenol A | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | bisphenol A results in increased expression of LMO7 mRNA | CTD | PMID:30951980 and PMID:32156529 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of LMO7 gene | CTD | PMID:28505145 | bisphenol F | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | bisphenol F results in increased expression of LMO7 mRNA | CTD | PMID:30951980 | bisphenol F | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of LMO7 mRNA | CTD | PMID:30951980 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of LMO7 mRNA | CTD | PMID:33453195 | caffeine | affects phosphorylation | ISO | LMO7 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of LMO7 protein | CTD | PMID:35688186 | calcium silicate | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | calcium silicate results in decreased expression of LMO7 mRNA | CTD | PMID:29279043 | carbon nanotube | affects expression | ISO | Lmo7 (Mus musculus) | 6480464 | Nanotubes and Carbon affects the expression of LMO7 mRNA | CTD | PMID:25554681 | chlordecone | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Chlordecone results in increased expression of LMO7 mRNA | CTD | PMID:33711761 | choline | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMO7 gene | CTD | PMID:20938992 | chromium(6+) | affects expression | ISO | Lmo7 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of LMO7 mRNA | CTD | PMID:28472532 | cisplatin | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of LMO7 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of LMO7 mRNA | CTD | PMID:27392435 | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of LMO7 mRNA | CTD | PMID:17898221 | copper(II) sulfate | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of LMO7 mRNA | CTD | PMID:19549813 | coumarin | affects phosphorylation | ISO | LMO7 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of LMO7 protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of LMO7 mRNA | CTD | PMID:29279043 | cycloheximide | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LMO7 mRNA] | CTD | PMID:11007951 | cyclosporin A | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of LMO7 mRNA | CTD | PMID:20106945 and PMID:25562108 | dibenzofurans | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Dibenzofurans results in increased expression of LMO7 mRNA | CTD | PMID:34254344 | diethyl maleate | decreases expression | EXP | | 6480464 | diethyl maleate results in decreased expression of LMO7 mRNA | CTD | PMID:21161181 | dorsomorphin | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of LMO7 mRNA | CTD | PMID:29803840 | entinostat | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | entinostat results in increased expression of LMO7 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of LMO7 mRNA | CTD | PMID:35436446 | ethanol | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Ethanol results in decreased expression of LMO7 mRNA | CTD | PMID:21955143 | ethanol | affects splicing | ISO | Lmo7 (Mus musculus) | 6480464 | Ethanol affects the splicing of LMO7 mRNA | CTD | PMID:30319688 | flurbiprofen | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Flurbiprofen results in increased expression of LMO7 mRNA | CTD | PMID:16949054 | folic acid | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | FR900359 | affects phosphorylation | ISO | LMO7 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of LMO7 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of LMO7 gene and [bisphenol S co-treated with Fulvestrant] results in increased methylation of LMO7 gene | CTD | PMID:31601247 | geldanamycin | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of LMO7 mRNA | CTD | PMID:26705709 | hexadecanoic acid | decreases phosphorylation | ISO | LMO7 (Homo sapiens) | 6480464 | Palmitic Acid results in decreased phosphorylation of LMO7 protein | CTD | PMID:28073184 | hydrogen peroxide | affects expression | ISO | LMO7 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of LMO7 mRNA | CTD | PMID:20044591 | irinotecan | affects expression | EXP | | 6480464 | Irinotecan affects the expression of LMO7 mRNA | CTD | PMID:20097248 | ivermectin | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of LMO7 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMO7 gene | CTD | PMID:20938992 | levofloxacin | decreases expression | EXP | | 6480464 | Levofloxacin results in decreased expression of LMO7 mRNA | CTD | PMID:24136188 | mercury dibromide | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of LMO7 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA | CTD | PMID:27188386 | methamphetamine | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of LMO7 mRNA | CTD | PMID:26307267 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of LMO7 gene | CTD | PMID:35440735 | methylmercury chloride | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of LMO7 mRNA | CTD | PMID:28001369 | morphine | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Morphine results in increased expression of LMO7 mRNA | CTD | PMID:21955143 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of LMO7 gene | CTD | PMID:33148267 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LMO7 mRNA | CTD | PMID:25566086 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LMO7 mRNA] | CTD | PMID:25566086 | N-nitrosodiethylamine | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of LMO7 mRNA | CTD | PMID:17854601 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LMO7 mRNA | CTD | PMID:18164116 | N-nitrosodiethylamine | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of LMO7 mRNA] | CTD | PMID:17854601 | nicotine | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Nicotine results in decreased expression of LMO7 mRNA | CTD | PMID:21955143 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of LMO7 mRNA | CTD | PMID:25729387 | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of LMO7 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LMO7 mRNA more ... | CTD | PMID:32699268 | ozone | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LMO7 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LMO7 mRNA | CTD | PMID:34911549 | p-chloromercuribenzoic acid | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of LMO7 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA | CTD | PMID:27188386 | panobinostat | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA | CTD | PMID:27188386 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of LMO7 gene | CTD | PMID:33148267 | phenobarbital | multiple interactions | ISO | Lmo7 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LMO7 mRNA] | CTD | PMID:19482888 | phenobarbital | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of LMO7 mRNA | CTD | PMID:19482888 | phenylmercury acetate | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of LMO7 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA | CTD | PMID:27188386 | phorbol 13-acetate 12-myristate | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA | CTD | PMID:16979875 | quercetin | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of LMO7 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of LMO7 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | serpentine asbestos | increases methylation | ISO | LMO7 (Homo sapiens) | 6480464 | Asbestos and Serpentine results in increased methylation of LMO7 exon | CTD | PMID:29523930 | sodium arsenate | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LMO7 mRNA | CTD | PMID:32525701 | sodium arsenite | increases stability | ISO | LMO7 (Homo sapiens) | 6480464 | sodium arsenite results in increased stability of LMO7 mRNA | CTD | PMID:25493608 | sodium arsenite | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of LMO7 mRNA | CTD | PMID:28595984 and PMID:34032870 | sodium arsenite | affects methylation | ISO | LMO7 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of LMO7 gene | CTD | PMID:28589171 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of LMO7 mRNA | CTD | PMID:19281266 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of LMO7 mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of LMO7 mRNA | CTD | PMID:31533062 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of LMO7 mRNA | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of LMO7 mRNA | CTD | PMID:31919559 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LMO7 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of LMO7 mRNA | CTD | PMID:23411599 | titanium dioxide | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of LMO7 mRNA | CTD | PMID:27760801 and PMID:29264374 | toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of LMO7 mRNA | CTD | PMID:22967744 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of LMO7 mRNA | CTD | PMID:25729387 | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of LMO7 mRNA | CTD | PMID:25729387 | tremolite asbestos | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | tremolite results in decreased expression of LMO7 mRNA | CTD | PMID:29279043 | trichostatin A | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of LMO7 mRNA | CTD | PMID:24935251 and PMID:26705709 | triclosan | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of LMO7 mRNA | CTD | PMID:30510588 | valdecoxib | decreases expression | EXP | | 6480464 | valdecoxib results in decreased expression of LMO7 mRNA | CTD | PMID:24136188 | valproic acid | increases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of LMO7 mRNA | CTD | PMID:19136453 and PMID:21427059 | valproic acid | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of LMO7 mRNA | CTD | PMID:24383497 more ... | valproic acid | decreases methylation | ISO | LMO7 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of LMO7 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | LMO7 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of LMO7 mRNA | CTD | PMID:25979313 | vancomycin | decreases expression | ISO | Lmo7 (Mus musculus) | 6480464 | Vancomycin results in decreased expression of LMO7 mRNA | CTD | PMID:18930951 | venlafaxine hydrochloride | decreases expression | ISO | LMO7 (Homo sapiens) | 6480464 | Venlafaxine Hydrochloride results in decreased expression of LMO7 mRNA | CTD | PMID:16341940 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of LMO7 mRNA | CTD | PMID:19015723 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of LMO7 gene | CTD | PMID:31079544 | zinc atom | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA | CTD | PMID:16979875 | zinc(0) | multiple interactions | ISO | LMO7 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA | CTD | PMID:16979875 | |
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
